Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: J Psychiatr Res. 2017 Mar 20;91:130–138. doi: 10.1016/j.jpsychires.2017.03.012

Table 2.

Characteristics of participants in the validation phase.

Fatigued (n = 13) Non-fatigued (n = 46) P Value
Age (years) 74.0 ± 2.8 76.3 ± 1.1 0.37
Race/ethnicity
 White 46.2% 56.5%
 Black/African American 53.8% 32.6% NA
 Asian 0% 8.7%
 Hispanic/Latino 0% 2.2%
BMI 30.7 ± 1.7 27.7 ± 0.6 0.051
ADT 77% 76% NA
Gleason Score 7.3 ± 0.4 7.0 ± 0.1 0.49
T stage
 T1c 46.2% 50% NA
 T2a-c 53.8% 50%
PSA (ng/mL)
 Baseline 9.18 ± 1.69 11.98 ± 2.75 0.60
 Two year post- RT 0.20 ± 0.04 0.86 ± 0.28 0.28

BMI: Body Mass Index; cm: centimeter; kg: kilogram; HAM-D: Hamilton Depression Rating Scale; ADT: androgen deprivation therapy; PSA: prostate specific antigen; RT: radiotherapy Values are mean ± standard error.